Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2010

01-09-2010 | Short Communication

Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies

Authors: Sabrina Lisi, Margherita Sisto, Dario Lofrumento, Maria Antonia Frassanito, Simone Caprio, Maria Luisa Romano, Vincenzo Mitolo, Massimo D’Amore

Published in: Clinical and Experimental Medicine | Issue 3/2010

Login to get access

Abstract

Apoptosis of the acinar and ductal epithelial cells of the salivary glands has been proposed as a mechanism possibly responsible for the impairment of the secretory function in Sjögren’s syndrome, an organ-specific autoimmune disorder characterized by destruction of these glandular structures. The presence of serum autoantibodies (Abs) directed against the ribonucleoproteic antigens Ro and La is one of the classification criteria used to identify Sjögren patients, and there is increasing evidence of the direct involvement of Abs in tissue pathogenesis. Our recent report demonstrated that anti-Ro and anti-La Abs are able to trigger the extrinsic pathway of apoptosis in the human salivary gland cells. To better understand how the anti-Ro and anti-La Abs exert their apoptotic effect, human caspase-8 gene expression was examined in primary human salivary gland epithelial cell (SGEC) cultures established from biopsies of labial minor salivary glands. To measure mRNA expression changes of initiating caspase-8, the real-time polymerase chain reaction was employed. This was combined with western blot to study the activation of caspase-8 detecting the cleaved form of caspase-8 and the cleaved poly (ADP-ribose) polymerase, downstream consequences of caspases activation. Data obtained suggest that the anti-Ro and anti-La Abs determine a transcriptional up-regulation and activation of caspase-8. Study of the mRNA in SGEC experimental model may provide insight into the signal transduction pathway stimulated by anti-nuclear autoantibodies.
Literature
1.
go back to reference Mountz JD, Wu J, Cheng J, Zhou T (1994) Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37:1415–1420CrossRefPubMed Mountz JD, Wu J, Cheng J, Zhou T (1994) Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37:1415–1420CrossRefPubMed
3.
go back to reference Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424CrossRefPubMed Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424CrossRefPubMed
4.
go back to reference Humphreys-Beher MG, Peck AB, Dang H, Talal N (1999) The role of apoptosis in the initiation of the autoimmune response in Sjögren’s syndrome. Clin Exp Immunol 116:383–387CrossRefPubMed Humphreys-Beher MG, Peck AB, Dang H, Talal N (1999) The role of apoptosis in the initiation of the autoimmune response in Sjögren’s syndrome. Clin Exp Immunol 116:383–387CrossRefPubMed
5.
go back to reference Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449CrossRefPubMed Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449CrossRefPubMed
6.
go back to reference Patel YI, McHugh NJ (2000) Apoptosis-new clues to the pathogenesis of Sjogren’s syndrome? Rheumatology 39:119–121CrossRefPubMed Patel YI, McHugh NJ (2000) Apoptosis-new clues to the pathogenesis of Sjogren’s syndrome? Rheumatology 39:119–121CrossRefPubMed
7.
go back to reference Jonsson R, Dowman SJ, Gordon T (2004) Sjögren’s syndrome. In: Koopman W (ed) Arthritis and allied conditions—a textbook in rheumatology, 15th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1681–1705 Jonsson R, Dowman SJ, Gordon T (2004) Sjögren’s syndrome. In: Koopman W (ed) Arthritis and allied conditions—a textbook in rheumatology, 15th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1681–1705
8.
go back to reference Vissink A, Kalk WW, Mansour K, Spijkervet FK, Bootsma H, Roodenburg JL et al (2003) Comparison of lachrymal and salivary gland involvement in Sjögren’s syndrome. Arch Otolaryngol Head Neck Surg 129:966–971CrossRefPubMed Vissink A, Kalk WW, Mansour K, Spijkervet FK, Bootsma H, Roodenburg JL et al (2003) Comparison of lachrymal and salivary gland involvement in Sjögren’s syndrome. Arch Otolaryngol Head Neck Surg 129:966–971CrossRefPubMed
9.
10.
go back to reference Ruiz-Arguelles A, Perez-romano B, Llorente L, Alarcón-Segovia D, Castellanos JM (1998) Penetration of anti-DNA antibodies into immature live cells. J Autoimmun 11:547–556CrossRefPubMed Ruiz-Arguelles A, Perez-romano B, Llorente L, Alarcón-Segovia D, Castellanos JM (1998) Penetration of anti-DNA antibodies into immature live cells. J Autoimmun 11:547–556CrossRefPubMed
11.
go back to reference Shiraga S, Adamus G (2002) Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 132:72–82CrossRefPubMed Shiraga S, Adamus G (2002) Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 132:72–82CrossRefPubMed
12.
go back to reference Sisto M, Lisi S, Lofrumento D, D’Amore M, Scagliusi P, Mitolo V (2007) Autoantibodies from Sjögren’s syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci 1108:418–425CrossRefPubMed Sisto M, Lisi S, Lofrumento D, D’Amore M, Scagliusi P, Mitolo V (2007) Autoantibodies from Sjögren’s syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci 1108:418–425CrossRefPubMed
13.
go back to reference Sisto M, Lisi S, Castellana D, Scagliusi P, D’Amore M, Caprio S et al (2006) Autoantibodies from Sjögren’s syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 27:38–49CrossRefPubMed Sisto M, Lisi S, Castellana D, Scagliusi P, D’Amore M, Caprio S et al (2006) Autoantibodies from Sjögren’s syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 27:38–49CrossRefPubMed
14.
go back to reference Sens DA, Hintz DS, Rudisill MT, Sens MA, Spicer SS (1985) Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab Invest 52:559–567PubMed Sens DA, Hintz DS, Rudisill MT, Sens MA, Spicer SS (1985) Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab Invest 52:559–567PubMed
15.
go back to reference Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren’s syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124:126–133CrossRefPubMed Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren’s syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124:126–133CrossRefPubMed
16.
go back to reference Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN (2001) Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J Immunol 166:3107–3113PubMed Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN (2001) Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J Immunol 166:3107–3113PubMed
17.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMed Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMed
18.
go back to reference Lisi S, Sisto M, Soleti R, Saponaro C, Scagliusi P, D’Amore M et al (2007) Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren’s syndrome and apoptosis in human salivary gland cell line A-253. J Oral Pathol Med 36:511–523PubMed Lisi S, Sisto M, Soleti R, Saponaro C, Scagliusi P, D’Amore M et al (2007) Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren’s syndrome and apoptosis in human salivary gland cell line A-253. J Oral Pathol Med 36:511–523PubMed
19.
go back to reference Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532–542CrossRefPubMed Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532–542CrossRefPubMed
20.
go back to reference Kuwano K, Yoshimi M, Maeyama T, Hamada N, Yamada M, Nakanishi Y (2005) Apoptosis signaling pathways in lung diseases. Med Chem 1:49–56CrossRefPubMed Kuwano K, Yoshimi M, Maeyama T, Hamada N, Yamada M, Nakanishi Y (2005) Apoptosis signaling pathways in lung diseases. Med Chem 1:49–56CrossRefPubMed
21.
go back to reference Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP (2008) Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ 15:530–544CrossRefPubMed Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP (2008) Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ 15:530–544CrossRefPubMed
22.
go back to reference Joo JH, Yoon SY, Kim JH, Paik SG, Min SR, Lim JS et al (2008) S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem 103:1183–1197CrossRefPubMed Joo JH, Yoon SY, Kim JH, Paik SG, Min SR, Lim JS et al (2008) S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem 103:1183–1197CrossRefPubMed
23.
go back to reference Huang W, Dobberfuhl A, Filippopoulos T, Ingelsson M, Fileta JB, Poulin NR et al (2005) Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma. Am J Pathol 167:673–681PubMed Huang W, Dobberfuhl A, Filippopoulos T, Ingelsson M, Fileta JB, Poulin NR et al (2005) Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma. Am J Pathol 167:673–681PubMed
24.
go back to reference Alikhani Z, Alikhani M, Boyd CM, Nagao K, Trackman PC, Graves DT (2005) Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 280:12087–12095CrossRefPubMed Alikhani Z, Alikhani M, Boyd CM, Nagao K, Trackman PC, Graves DT (2005) Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 280:12087–12095CrossRefPubMed
25.
go back to reference Fulda S, Debatin KM (2002) IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21:2295–2308CrossRefPubMed Fulda S, Debatin KM (2002) IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21:2295–2308CrossRefPubMed
Metadata
Title
Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies
Authors
Sabrina Lisi
Margherita Sisto
Dario Lofrumento
Maria Antonia Frassanito
Simone Caprio
Maria Luisa Romano
Vincenzo Mitolo
Massimo D’Amore
Publication date
01-09-2010
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 3/2010
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-009-0087-4

Other articles of this Issue 3/2010

Clinical and Experimental Medicine 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine